NCT04497129

Brief Summary

ROMTech is focused on transforming the healthcare market by delivering lower extremity rehabilitation systems that are effective, efficient for patient use, cost-effective, and provide better patient outcomes while simultaneously decreasing rehabilitation and overall recovery times.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for not_applicable knee-osteoarthritis

Timeline
Completed

Started Aug 2020

Geographic Reach
1 country

5 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 21, 2020

Completed
14 days until next milestone

First Posted

Study publicly available on registry

August 4, 2020

Completed
13 days until next milestone

Study Start

First participant enrolled

August 17, 2020

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

July 22, 2025

Status Verified

July 1, 2025

Enrollment Period

1.4 years

First QC Date

July 21, 2020

Last Update Submit

July 21, 2025

Conditions

Keywords

ROMTechPortableConnectOsteoarthritisRemote monitoringHome Health Physical TherapyOutpatient Physical TherapyRehabilitationPhysical Therapy

Outcome Measures

Primary Outcomes (10)

  • Range of Motion

    Knee Flexion and Extension

    Screening

  • Range of Motion

    Knee Flexion and Extension

    Baseline

  • Range of Motion

    Knee Flexion and Extension

    Week 1

  • Range of Motion

    Knee Flexion and Extension

    Week 2

  • Range of Motion

    Knee Flexion and Extension

    Week 3

  • Range of Motion

    Knee Flexion and Extension

    Week 4

  • Range of Motion

    Knee Flexion and Extension

    Week 5

  • Range of Motion

    Knee Flexion and Extension

    Week 6

  • Range of Motion

    Knee Flexion and Extension

    Week 7 (End of Treatment)

  • Range of Motion

    Knee Flexion and Extension

    Week 9 (Follow-up)

Secondary Outcomes (89)

  • Timed up and go (TUG) performance

    Screening

  • Timed up and go (TUG) performance

    Week 4

  • Timed up and go (TUG) performance

    Week 7 (End of Treatment)

  • Timed up and go (TUG) performance

    Week 9 (Follow-UP)

  • Knee pain as measured on a 10-point pain scale

    Screening

  • +84 more secondary outcomes

Other Outcomes (26)

  • Patient Satisfaction Questionnaire via 4-point scale

    Week 1

  • Patient Satisfaction Questionnaire via 4-point scale

    Week 2

  • Patient Satisfaction Questionnaire via 4-point scale

    Week 3

  • +23 more other outcomes

Study Arms (2)

ROMTech PortableConnect

EXPERIMENTAL

Rehabilitation Using the ROMTech PortableConnect Device

Device: ROMTech PortableConnect

Traditional Rehabilitation & Continuous Passive Motion Device

ACTIVE COMPARATOR

Combination of OPPT and HHPT in conjunction with CPM device usage

Device: Traditional Rehabilitation and CPM Device

Interventions

ROMTech PortableConnect (ROMTechPC) therapy will be completed four to five times per day for 6 minutes duration for 6 weeks. The intervention will be administered using the portable rehabilitation unit.

ROMTech PortableConnect

Continuous passive motion (CPM) with standard of care HHPT and OPPT rehabilitation program (CPM with SOC). Therapy with the CPM will be completed daily from day 0 through week 3 for a total of 6 to 8 hours per day. The HHPT and OPPT rehabilitation program will be a 6-week program based on SOC goals.

Traditional Rehabilitation & Continuous Passive Motion Device

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male or female ≥18 years of age at screening visit.
  • Documentation of a definitive diagnosis of osteoarthritis of the knee requiring total knee arthroplasty.
  • Scheduled or willing to schedule TKA procedure within the timelines consistent with the study enrollment period. This includes up to a 28-day screening window prior to the scheduled surgery.
  • Willing to consent to outpatient, home-based physical therapy, CPM, or the ROMTech protocol
  • Able to provide written informed consent.
  • Willing and able to participate in and complete all study assessments, questionnaires, and procedure

You may not qualify if:

  • Inability to provide informed consent.
  • Inability to understand and complete study related assessments and procedures.
  • Other scheduled surgical knee procedures in addition to the TKA.
  • Presence of a condition or abnormality that in the opinion of the investigator would compromise the safety of the subject or the quality of the data.
  • History of musculoskeletal or neurological disorders that limit physical function including but not limited to severe spine OA, contralateral leg issues limiting mobility, and other disorders as identified by the investigator
  • Planned additional knee joint surgery within 3 months of the primary scheduled TKA

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

OrthoArizona

Gilbert, Arizona, 85234, United States

Location

Aventura Orthopaedics

Aventura, Florida, 33180, United States

Location

Orthopaedic Associates of West Florida

Clearwater, Florida, 33756, United States

Location

Institute of Orthopedic Research and Innovation

Coeur d'Alene, Idaho, 83814, United States

Location

OrthoSouth

Memphis, Tennessee, 38119, United States

Location

MeSH Terms

Conditions

Osteoarthritis, KneeArthralgiaOsteoarthritis

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Ryan Nunley, MD

    ROM Tech

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 21, 2020

First Posted

August 4, 2020

Study Start

August 17, 2020

Primary Completion

December 31, 2021

Study Completion

December 31, 2021

Last Updated

July 22, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations